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Objective  To evaluate the eff  ects of power walking (PW) training on a treadmill in patients with coronary heart 
disease (CHD) and to compare the cardiovascular eff  ects of PW with usual walking (UW). 
Method  Patients were recruited as participants in phase 2 cardiac rehabilitation program after receiving 
percutaneous coronary intervention (PCI) due to acute coronary syndrome from our hospital. Th  e  participants 
were divided into the PW group (n=16) and UW group (n=18). All participants received graded exercise test (GXT) 
and signifi  cant diff  erence in maximal oxygen consumption (VO2Max) was not observed between the groups. Aerobic 
exercise training on treadmill was given for 50 minutes per session, three times a week, for six weeks. Physiological 
and hematological parameters were tested before and 6 weeks after the cardiac rehabilitation program. Exercise 
duration, VO2Max, heart rate, blood pressure, and rate pressure product were evaluated through graded exercise 
test. Hematological measurements included serum lipid profi  le, and high-sensitivity C reactive protein (hs-CRP).
Results  Th   ere were no signifi  cant diff  erences in resting heart rate, maximal heart rate, resting systolic and diastolic 
blood pressures, lipid profi  le, hs-CRP, VO2Max, and RPP between the PW group and UW group. However, after 6 
weeks of the intervention, VO2Max in the PW group (36.03±5.69 ml/kg/min) was signifi  cantly higher than that in the 
UW group (29.73±5.63 ml/kg/min) (p<0.05).
Conclusion  After six weeks of phase 2 cardiac rehabilitation program, the PW group showed significant 
improvement in VO2Max than the UW group. Thus, it will beneficial to recommend power walking in cardiac 
rehabilitation program.
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INTRODUCTION
  Improvement in physical activity and exercise capacity 
is important in primary and secondary preventions of 
cardiovascular disease.
1 The positive effects of walking 
on exercise capacity and physical health along with 
metabolic and psychological health
2-4 for healthy people, 
as well as for people with various chronic disorders have 
been proven through research.
5-9 Walking exercise and 
energy consumption has a U-shaped relationship, where 
decreased walking speed leads to increased need for 
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energy or oxygen consumption. A normal adult walking 
at a speed of 4.50-4.86 km/hr has the least aerobic 
requirement and relatively low exercise intensity. It has 
been reported that running is preferred over walking at a 
speed equal to or greater than 8 km/hr, since running at 
the higher speed consumes less oxygen than walking.
10,11 
Moreover, the degree of stride width during walking 
exercise could greatly aff  ect the aerobic demands during 
walking exercise, since increased speed increases the 
stride width and vice versa. Walking exercise at a speed 
around 4.67-4.81 km/hr could especially be effective in 
improving cardiovascular endurance, as well as weight 
and percent body fat reduction in middle-aged adults 
with sedentary lifestyles.
12
  Power walking is a form of exercise where active upper 
body movement is added to the usual walking exercise. 
Power walking is a fast walking exercise done at a speed 
of 6 to 8 km/h with the back straight and the center of 
gravity moving from heal, sole, and to hallux. Th  e  elbow 
joints are bent 90 degrees to actively swing back and forth 
during movement.
12
  Th   e energy consumption increases up to 55% in walking 
exercise with the arm movement in comparison to just 
walking exercise without arm movement. Power walking 
has advantages of greater energy consumption than 
with running at a speed equal to or greater than 8 km/
hr. Moreover, power walking consumes comparatively 
greater energy during exercise, while being at a lower 
intensity. Despite the advantages of power walking, 
the exercise effects have not been reported in cardiac 
rehabilitation programs.
13
  Therefore, the effects of power walking on cardiac 
rehabilitation have been evaluated in this study by divid-
ing the cardiac rehabilitation patients into the power 
walking group and regular walking group for their 
exercise capacities.
MATERIALS AND METHODS
Subjects
  The subjects were patients who had been diagnosed 
with acute coronary syndrome and had undergone 
percutaneous coronary intervention (PCI). The patients 
were enrolled at our rehabilitation clinic for graded 
exercise test and 6 weeks of aerobic exercise program 
under clinical surveillance; this was a phase 2 of a 
cardiac rehabilitation program. Th   e patients enrolled as 
participants to the study after detailed explanations of 
the purpose and procedures of the study. Th  ose  patients 
with contraindications to exercise or clinical risk factors, 
such as musculoskeletal, neurological, pulmonary or 
metabolic disorder were all excluded from the study.
Graded exercise test (GXT)
  Symptom-limited exercise tolerance tests were 
carried out using a modified Bruce protocol, which is 
a GXT protocol for cardiovascular disorder patients 
with a gradual increase in the exercise loads. The test 
was terminated according to the American Heart 
Association’s (AHA) early termination criteria upon 
monitoring of abnormal chest pain, blood pressure, 
pulse, EKG, or subjective symptoms by the patients such 
as dizziness or light headedness.
14 A real-time recording 
12-channel EKG for GXT Q4500 (Quinton Instrument 
Co., Boston, USA), a respiratory gas analyzer Quinton 
metabolic cart (Quinton Instrument Co., Boston, 
USA), an automatic blood pressure and pulse monitor 
Model412, (Quinton Instrument Co., Boston, USA), and 
a treadmill for GXT Medtrack ST 55 (Quinton Instrument 
Co., Boston, USA) were used during the test. Resting 
heart rate, maximal heart rate, resting systolic and 
diastolic blood pressure, resting diastolic blood pressure, 
maximum exercise duration, metabolic equivalents 
(METs), resting and maximal heart rates, blood pressure, 
maximal and submaximal rate pressure product (RPP), 
and VO2max were recorded during graded exercise test for 
all patients. Borg’s rate of perceived exertion with 6-20 
scale was used to measure the rate of perceived exertion 
(RPE). Administration of all medications was requested 
to either discontinue or maintain existing dosage for the 
duration of graded exercise test and exercise program. All 
patients received treatment at the department of internal 
medicine as inpatients, followed by a visit to the cardiac 
rehabilitation clinic for exercise tolerance tests within 
a week of discharge. The patients participated in the 
cardiac rehabilitation program one to 2 days after graded 
exercise tests with the exercise intensity calculated 
based on the Karvonen formula
15 (maximal heart rate - 
resting heart rate x exercise intensity (%)+resting heart 
rate) with the target heart rate (%) between 60% and 85% 
for exercise intensity. Heart rates and ECG (myocardial 
ischemia and arrhythmia) were monitored real-time with Power-walking in Phase 2 Cardiac Rehabilitation
135 www.e-arm.org
a wireless EKG attached to the patients during the cardiac 
rehabilitation exercise program. Blood pressure was 
measured 2 minutes prior to the termination of exercise. 
Th   e exercise intensity was limited to the target heart rate 
of 60 to 85% based on the Karvonen formula.
Exercise procedure and measured parameters
  Cardiac rehabilitation exercise was conducted 3 times 
a week for 6 weeks with the elbow joints flexed to 90 
degrees and the arms swung back and forth during 
walking. The exercise intensities were set at 60% of the 
target heart rate during the first 2 weeks, 70% during 
3
rd and 4
th weeks, and 85% during 5
th and 6
th weeks. 
Identical exercise protocol was prescribed to the UW 
group except for intermittently holding onto the handles 
while walking (Fig. 1). Resting heart rate (RHR), maximal 
heart rate (MHR), resting systolic blood pressure (RSBP), 
resting diastolic blood pressure (RDBP), maximal oxygen 
consumption (VO2max), maximal exercise duration, and 
metabolic equivalent (MET) were measured via graded 
exercise test (GXT) and lipid profile and hs-CRP were 
tested through hematological analysis after 6 weeks of 
cardiac rehabilitation program for comparison.
Statistical analysis 
  The results were analyzed for means and standard 
deviations with SPSS/PC+ version 12.0, a statistical 
package for Windows. Chi-square test and Wilcox’s 
rank-sum test were conducted to compare age, sex, 
BMI, diagnosis, lipid profile, and medication between 
the groups. Wilcoxon’s rank-sum test and conducted 
to compare the test variables before and after exercise 
between the groups. Wilcoxon’s signed rank test was 
conducted to compare the mean differences of the 
variables between the groups and pre and post exercise. 
Th  e  signifi  cance level was set at p<0.05.
RESULTS
General characteristics of the subjects
  The subjects were randomly assigned into either the 
power walking group (PW) or usual walking group (UW) 
for the study. The mean ages were 55.25±10.28 and 
59.00±9.4 for PW (n=16) and UW (n=18), respectively. 
PW was composed of 14 men and 2 women, and UW 
was composed of 17 men and 1 woman. There were 
no significant differences in body mass index (BMI), 
medication, past history, physical status, exercise 
capacity, pre-exercise lipid profile or hs-CRP, between 
the groups (Table 1).
Changes in exercise capacity
  Resting heart rate (RHR), maximal heart rate (MHR), 
resting systolic blood pressure (RSBP), resting diastolic 
blood pressure (RDBP), rate pressure product (RPP), 
metabolic equivalent (MET), exercise duration, and 
Fig. 1. Th   e power walking group (A) 
was instructed to swing both arms 
back and forth while the elbow joint 
was bent at 90 degrees. The usual 
walking group (B) was instructed to 
intermittently grasp on the handles 
for safety during walking.Chul Kim, et al.
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VO2max were compared for test variables pre- and post-
6-week intervention in both groups. Heart rate (HR), 
systolic blood pressure (SBP), diastolic blood pressure 
(DBP), metabolic equivalent (MET), and exercise 
duration did not show signifi  cant diff  erences between the 
groups. However, VO2max and metabolic equivalent (MET) 
were signifi  cantly higher in PW than in UW after 6 weeks 
of exercise (Table 2). 
Diﬀ  erences in lipid proﬁ  le and hs-CRP
  Changes in lipid profile and hs-CRP were measured 
between PW and UW before and after 6 weeks of exercise 
intervention. All variables of lipid profi  le and hs-CRP did 
not show signifi  cant changes before and after 6 weeks of 
exercise between the groups (Table 3).
DISCUSSION
  Improved exercise capacity is believed to be more closely 
related to the peripheral effects than to central effects 
of the heart in the fi  eld of cardiac rehabilitation.
16 It was 
noted that peripheral muscles utilize oxygen obtained 
from aerobic exercises more effectively by increasing 
the number and size or aerobic related enzymes and 
mitochondria, as well as increase the level of myoglobin 
and capillary vessels to the striated muscles.
17,18 Patients 
with coronary artery disease can avoid possible physical 
disability and further prevent recurrence of CAD and 
mortality.
  Myocardial oxygen demands during active daily activities 
can be diminished through aerobic exercise by increasing 
maximum oxygen consumption, and decreasing 
Table 1. General Characteristics of the Subjects
PW (n=16) UW (n=18) p-value
Age (years)   55.25±10.28 59.00±9.47 0.279
Sex (male) 14 (87.5%)  17 (94.4%) 0.591
BMI 25.46±2.64 24.62±1.68 0.289
Past history
Unstable angina   8 (50.0%)    6 (33.3%)
Myocardial infarction   8 (50.0%)  12 (66.7%) 0.324
Lipid profi  le
Total cholesterol (mg/dl) 179.94±45.50 194.56±43.74 0.347
TG (mg/dl) 140.25±17.60 151.11±17.72 0.083
HDL-C (mg/dl) 44.88±8.83 39.89±6.11 0.062
LDL-C (mg/dl) 118.00±25.71 128.22±32.38 0.320
hs-CRP (mg/dl)   0.208±0.069   0.258±0.091 0.086
Medication
Anticoagulant 15 (93.8%) 18 (100%) 0.471
ACEI   9 (56.3%)  12 (66.7%) 0.533
ATII   2 (12.5%)    3 (16.7%) 0.725
Beta-blockers   4 (25.0%)    6 (33.3%) 0.595
Nitrate 10 (62.5%)    7 (38.9%) 0.169
CCB   2 (12.4%)  1 (5.6%) 0.591
Diuretics 0 0
Statin 10 (62.5%)  13 (72.2%) 0.545
Carvedilol   6 (37.5%)    5 (27.8%) 0.545
Values are mean±standard deviation
BMI: Body mass index, TG: Triglyceride, HDL-C: High density lipoprotein cholesterol, LDL-C: Low density lipoprotein 
cholesterol, hs-CRP: High sensitivity C-reactive protein, ACEI: Angiotensin converting enzyme inhibitor, ATII: 
Angiotensin II receptor antagonist, CCB: Calcium channel blocker, PW: Power walking group, UW: Usual walking 
groupPower-walking in Phase 2 Cardiac Rehabilitation
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maximal heart rate and rate pressure product.
17 The rate 
of oxygen consumption is determined by the difference 
between cardiac output and arteriovenous oxygen 
difference. Cardiac output is decided by stroke volume 
and heart rate which in turn increase the maximum 
oxygen consumption.
19 Although the differences were 
not observed in systolic blood pressure, diastolic blood 
pressure, resting heart rate, maximal and sub-maximal 
rate pressure product before and after 6 weeks of exercise 
intervention between the groups, signifi  cant diff  erence in 
VO2max was observed between the groups. 
  Th   e results of the EMG measurements of the upper and 
lower limbs by Cho et al.
20 indicated that the muscular 
activities observed in all upper and lower limb muscles 
in power walking subjects were greater than that found 
in those subjects that walked at a slower pace. EMG 
activities were especially higher in biceps brachii of 
the upper extremity, and medial gastrocnemius, lateral 
gastrocnemius, and soleus of the lower extremity. Such 
results suggest that comparatively higher physical activity 
ranges and muscular activities during power walking 
may be related to higher maximal oxygen consumption 
in comparison to usual walking.
  One metabolic equivalent (MET) refers to the amount 
Table 2. Comparison of Hemodynamics 6 Weeks after Exercise Program between PW and UW
Variables
Baseline After 6 weeks
PW UW PW UW
RHR (bpm)   71.19±12.06 65.11±6.04     68.88±10.11 62.56±8.08
MHR (bpm) 146.19±15.52 135.83±17.81  152.44±9.83* 147.11±9.27*
RSDP (mmHg) 119.63±18.34 113.06±14.16 114.63±8.17 121.11±14.59
RDBP (mmHg) 77.13±7.73 72.17±8.46   78.25±7.07 76.22±6.67
MSBP (mmHg) 176.81±36.24 175.22±31.10   170.75±22.18 178.89±24.90
MDBP (mmHg) 80.69±6.90   73.72±13.35     76.50±11.03   74.83±11.55
MRPP 25,870.31±6,406.93 22,159.94±6,081.43   25,936.25±3,971.94 24,406.06±5,687.65
SRPP 15,254.06±4,393.14 14,195.06±3,544.30     11,869.94±1,782.00*   12,820.00±2,364.00*
VO2Max (ml/kg/min) 28.54±6.08 27.16±4.43      36.03±5.69*
†   29.74±5.63*
Duration (sec)   866.63±107.05   854.67±106.65     989.00±90.25*     944.17±111.49*
MET   8.11±1.84   7.86±1.27     10.13±1.84*
†     9.17±1.08*
Values are mean±standard deviation
PW: Power walking group, UW: Usual walking group, RHR: Resting heart rate, MHR: Maximal heart rate, RSBP: Resting 
systolic blood pressure, RDBP: Restig diastolic blood pressure, MSBP: Maximal systolic blood pressure, MDBP: 
Maximal diastolic blood pressure, MRPP: Maximal rate pressure product, SRPP: Sub-maximal rate pressure product, 
VO2Max: Maximum oxygen consumption, MET: Metabolic equivalent 
*p<0.05 by Wilcoxon’s signed rank test, 
†p<0.05 by Wilcoxon’s rank-sum test
Table 3. Comparison of hs-CRP and Lipid Profi  le 6 Weeks after Exercise Program between PW and UW
Variables
Baseline After 6 weeks
PW UW PW UW
Total cholesterol (mg/dl) 179.94±45.50 194.56±43.74 139.69±27.61* 145.39±24.62*
TG (mg/dl) 140.25±17.60 151.11±17.72 113.13±20.14* 123.33±18.68*
HDL-C (mg/dl) 44.88±8.83 39.89±6.11 49.38±9.32* 45.28±7.57*
LDL-C (mg/dl) 118.00±25.71 128.22±32.38   97.31±18.80*   97.83±15.93*
hs-CRP (mg/dl)   0.209±0.067   0.258±0.087     0.067±0.0412*   0.087±0.059*
Values are mean±standard deviation
PW: Power walking group, UW: Usual walking group, TG: Triglyceride, HDL: High density lipoprotein, LDL: Low 
density lipoprotein, hs-CRP: High sensitivity C- reactive protein
*p<0.05 by Wilcoxon’s signed rank testChul Kim, et al.
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of oxygen consumed during one’s resting state (3.5 
ml/kg/min). MET is obtained by dividing the value 
of VO2max, acquired during graded exercise test with a 
gas exchange analyzer, by 3.5 ml/kg/min. Increased 1 
MET is related to decreased risk of death by coronary 
artery disease in healthy subjects in comparison to 
unhealthy subjects. Increased 1 MET in those with and 
without CVD risk factors showed 28-51% reduction in 
fatal cardiac death and 17-29% reduction in non-fatal 
cardiac death. Therefore, increased 1 MET is a strong 
risk prognosis factor in cardiac death.
21 Myers et al.
22 
did a follow-up study with 3,679 patients with coronary 
artery disease for 6.2±3.7 years after measuring their 
VO2max with graded exercise tests. Exercise capacity of the 
patients with METs of ≤4.9 METs and ≤10.7 METs had 
mortality risks of 4.1 and 1.0, respectively. Dorn et al.
23 
reported that the mortality rates of the acute myocardial 
infarction patients decreased approximately 10% for 
every 1 MET increased through the patient progression 
observations. A signifi    cant increase in VO2max alone could 
have adequate sig  nificance, despite the insignificant 
changes in other variables between PW and UW, based 
on such previous results. Aerobic exercise plays an 
important role in cardiovascular disease prevention and 
off  ers therapeutic eff  ects by decreasing total cholesterol, 
triglycerides and increasing high-density lipoprotein-
cholesterol.
24 Moreover, it has been proven that hs-CRP, a 
major risk factor marker for mortality in acute myocardial 
infarction patients, can be decreased through aerobic 
exercise. Fallon et al.
25 reported that regularly played 
soccer decreased hs-CRP concentration. Mattusch et al.
26 
reported that 9 months of endurance running decreased 
hs-CRP concentration by 31%. Smith et al.
27 reported that 
high risk patients (n=43) with ischemic cardiovascular 
disease had 35% reduction in TNF-α and hs-CRP after 6 
months of exercise. In this study, hs-CRP and lipid profi  le 
significantly decreased post-exercise in both groups 
without signifi  cant changes in between groups.
  Myocardial oxygen consumption during exercise 
indicates the rate pressure product (RPP) during equal 
workloads. It plays a vital role in decreasing the incidence 
of angina due to its close relationship to angina threshold. 
Additional previously studies have reported that an 
increased myocardial ischemic threshold by physical 
activity for anti-ischemic effects further increased the 
ability to perform at greater work intensities.
28 Ahn et al.
29 
reported that the rate pressure product was signifi  cantly 
lowered in myocardial ischemia patients that exercised in 
comparison to myocardial ischemia patients that did not 
exercise, with a signifi  cant decrease in maximal pressure 
rate product at equal workloads. Such significant 
improvement can be credited to regular aerobic exercise 
by improving exercise tolerance and exercise duration, as 
well as increasing heart rates and systolic blood pressure.
  Th   ere are some limitations to this study, which should 
be considered in future studies. The limitations include 
an inadequate number of patients and 6 weeks of short-
term exercise intervention for adequate observation 
of the significant changes in variables. Further studies 
should be conducted with an adequate number of 
patients with long-term observation of their progress.
CONCLUSION
  Th  e  signifi  cantly increased maximum oxygen consump-
tion (VO2max) of the power walking group with acute coro-
nary syndrome in comparison to the usual walking group 
with coronary syndrome suggests the possibility that 
power walking should be part of the recommendation 
for a more aggressive mode of cardiac rehabilitation 
exercise.
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